Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Study.

Foley, Peter; Tsai, Tsen-Fang; Rodins, Karl; Hamadah, Issam Ribhi; Ammoury, Alfred; Dayem, Hussein Abdel; Abdallah, Mahmoud; Crowe, Susanne; Haas, Silvia; Pournara, Effie; Jagiello, Piotr; Huang, Yu-Huei

Foley, Peter; Tsai, Tsen-Fang; Rodins, Karl; Hamadah, Issam Ribhi; Ammoury, Alfred; Dayem, Hussein Abdel; Abdallah, Mahmoud; Crowe, Susanne; Haas, Silvia; Pournara, Effie; Jagiello, Piotr; Huang, Yu-Huei.

Afiliação

Foley P; Skin Health Institute, Carlton, Victoria, Australia.
Tsai TF; National Taiwan University Hospital, Taipei, Taiwan.
Rodins K; Northern Dermatology, Chermside, Queensland, Australia.
Hamadah IR; King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Ammoury A; Saint George Hospital University Medical Center, Beirut, Lebanon.
Dayem HA; Mediclinic, Al-Noor Hospital, Abu Dhabi, United Arab Emirates.
Abdallah M; Department of Dermatology and Venereology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Crowe S; Novartis Ireland Ltd, Dublin, Ireland.
Haas S; Novartis Pharma AG, Basel, Switzerland.
Pournara E; Novartis Pharma AG, Basel, Switzerland.
Jagiello P; Novartis Pharma AG, Basel, Switzerland.
Huang YH; Chang Gung Memorial Hospital Linkou and Chang Gung University, Tao-yuan, Taiwan. huang3764@yahoo.com.tw.